Madrigal Pharmaceuticals, Inc. SEC filings MDGL

Madrigal Pharmaceuticals, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Nov 12, 2010. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Madrigal Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
144 Notice of proposed sale Sep 28, 2026 —
4 Insider transaction Sep 11, 2026 Sep 9, 2026
144 Notice of proposed sale Sep 11, 2026 —
144 Notice of proposed sale Sep 9, 2026 —
4 Insider transaction Aug 20, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 20, 2026 —
4 Insider transaction Aug 18, 2026 Aug 15, 2026
3 Initial insider ownership Aug 18, 2026 Aug 11, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 12, 2026 Aug 11, 2026
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2026 —
4 Insider transaction Jul 20, 2026 Jul 17, 2026
144 Notice of proposed sale Jul 20, 2026 —
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
S-8 Employee stock plan registration Jun 17, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 1, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 22, 2026 May 22, 2026
144 Notice of proposed sale May 22, 2026 —
4 Insider transaction May 18, 2026 May 18, 2026
144 Notice of proposed sale May 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
8-K Current report
Officer or director change
Apr 28, 2026 Apr 22, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 6, 2026 Mar 6, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 2, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 24, 2026 Feb 23, 2026
10-K Annual report Feb 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 19, 2026 Feb 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Material agreement
Jan 30, 2026 Jan 29, 2026
4 Insider transaction Jan 26, 2026 Jan 26, 2026
4 Insider transaction Jan 26, 2026 Jan 26, 2026
144 Notice of proposed sale Jan 26, 2026 —
4 Insider transaction Jan 26, 2026 Jan 26, 2026
144 Notice of proposed sale Jan 26, 2026 —
4 Insider transaction Jan 26, 2026 Jan 26, 2026
144 Notice of proposed sale Jan 26, 2026 —
144 Notice of proposed sale Jan 26, 2026 —
4 Insider transaction Jan 20, 2026 Jan 20, 2026
144 Notice of proposed sale Jan 20, 2026 —
4 Insider transaction Jan 20, 2026 Jan 20, 2026
144 Notice of proposed sale Jan 20, 2026 —
4 Insider transaction Jan 20, 2026 Jan 15, 2026
3 Initial insider ownership Jan 20, 2026 Jan 12, 2026
144 Notice of proposed sale Jan 20, 2026 —
4 Insider transaction Jan 13, 2026 Jan 9, 2026
4 Insider transaction Jan 13, 2026 Jan 9, 2026
4 Insider transaction Jan 13, 2026 Jan 9, 2026
4 Insider transaction Jan 13, 2026 Jan 9, 2026
144 Notice of proposed sale Jan 9, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 12, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 12, 2025 —
4 Insider transaction Dec 12, 2025 Dec 10, 2025
4 Insider transaction Dec 12, 2025 Dec 10, 2025
8-K Current report
Officer or director change
Dec 11, 2025 Dec 5, 2025
144 Notice of proposed sale Dec 10, 2025 —
144 Notice of proposed sale Dec 10, 2025 —
4 Insider transaction Dec 4, 2025 Dec 3, 2025
144 Notice of proposed sale Dec 4, 2025 —
4 Insider transaction Dec 3, 2025 Dec 2, 2025
144 Notice of proposed sale Dec 2, 2025 —
4 Insider transaction Nov 21, 2025 Nov 21, 2025
144 Notice of proposed sale Nov 21, 2025 —
4 Insider transaction Nov 14, 2025 Nov 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
144 Notice of proposed sale Nov 13, 2025 —
4 Insider transaction Nov 7, 2025 Nov 5, 2025
144 Notice of proposed sale Nov 5, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
S-8 Employee stock plan registration Sep 11, 2025 —
144 Notice of proposed sale Sep 9, 2025 —
4 Insider transaction Sep 9, 2025 Sep 9, 2025
144 Notice of proposed sale Aug 29, 2025 —
4 Insider transaction Aug 21, 2025 Aug 21, 2025
144 Notice of proposed sale Aug 21, 2025 —
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
144 Notice of proposed sale Aug 20, 2025 —
4 Insider transaction Aug 18, 2025 Aug 18, 2025
144 Notice of proposed sale Aug 18, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
4 Insider transaction Aug 15, 2025 Aug 15, 2025
144 Notice of proposed sale Aug 15, 2025 —
144 Notice of proposed sale Aug 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 13, 2025 Aug 13, 2025
4 Insider transaction Aug 13, 2025 Aug 11, 2025
4 Insider transaction Aug 13, 2025 Aug 11, 2025
144 Notice of proposed sale Aug 13, 2025 —
144 Notice of proposed sale Aug 12, 2025 —
144 Notice of proposed sale Aug 12, 2025 —
144 Notice of proposed sale Aug 11, 2025 —
144 Notice of proposed sale Aug 11, 2025 —
4 Insider transaction Aug 5, 2025 Aug 1, 2025
3 Initial insider ownership Aug 5, 2025 Aug 1, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Regulation FD disclosure
Jul 30, 2025 Jul 30, 2025
4 Insider transaction Jul 22, 2025 Jul 18, 2025
4 Insider transaction Jul 22, 2025 Jul 18, 2025
8-K Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
Jul 22, 2025 Jul 17, 2025
144 Notice of proposed sale Jul 18, 2025 —
144 Notice of proposed sale Jul 18, 2025 —
4 Insider transaction Jul 18, 2025 Jul 16, 2025
4 Insider transaction Jul 18, 2025 Jul 16, 2025
144 Notice of proposed sale Jul 17, 2025 —
144 Notice of proposed sale Jul 17, 2025 —
144 Notice of proposed sale Jul 16, 2025 —
144 Notice of proposed sale Jul 16, 2025 —
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
S-8 Employee stock plan registration Jun 20, 2025 —
8-K Current report
Shareholder vote results
Jun 20, 2025 Jun 20, 2025
4 Insider transaction May 16, 2025 May 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 20, 2025
3 Initial insider ownership Apr 24, 2025 Apr 21, 2025
8-K Current report
Officer or director change
Apr 17, 2025 Apr 16, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Mar 14, 2025 Mar 12, 2025
144 Notice of proposed sale Mar 13, 2025 —
144/A Filing Mar 13, 2025 —
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
3 Initial insider ownership Mar 12, 2025 Mar 10, 2025
144 Notice of proposed sale Mar 12, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 11, 2025 Mar 9, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
144 Notice of proposed sale Mar 5, 2025 —
4 Insider transaction Mar 4, 2025 Feb 28, 2025
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Feb 28, 2025 —
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
144 Notice of proposed sale Feb 27, 2025 —
144 Notice of proposed sale Feb 27, 2025 —
10-K Annual report Feb 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Jan 27, 2025 Jan 24, 2025
4 Insider transaction Jan 27, 2025 Jan 24, 2025
4 Insider transaction Jan 27, 2025 Jan 24, 2025
4 Insider transaction Jan 27, 2025 Jan 24, 2025
144 Notice of proposed sale Jan 24, 2025 —
144 Notice of proposed sale Jan 24, 2025 —
144 Notice of proposed sale Jan 24, 2025 —
144 Notice of proposed sale Jan 24, 2025 —
4 Insider transaction Jan 17, 2025 Jan 17, 2025
4 Insider transaction Jan 17, 2025 Jan 17, 2025
4 Insider transaction Jan 17, 2025 Jan 17, 2025
144 Notice of proposed sale Jan 17, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MDGL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
West Conshohocken, PA
SEC filer status
Large accelerated filer
SEC CIK
1157601
Former names
MADRIGAL PHARMACEUTICALS, INC. (until Nov 3, 2026); SYNTA PHARMACEUTICALS CORP (until Aug 1, 2016)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.